NO944112D0 - Rekombinat stimuleringsfaktor for neu-reseptoren - Google Patents

Rekombinat stimuleringsfaktor for neu-reseptoren

Info

Publication number
NO944112D0
NO944112D0 NO944112A NO944112A NO944112D0 NO 944112 D0 NO944112 D0 NO 944112D0 NO 944112 A NO944112 A NO 944112A NO 944112 A NO944112 A NO 944112A NO 944112 D0 NO944112 D0 NO 944112D0
Authority
NO
Norway
Prior art keywords
recombinant
stimulation factor
neu receptor
neu
receptor
Prior art date
Application number
NO944112A
Other languages
English (en)
Other versions
NO944112L (no
Inventor
Duanzhi Wen
Yosef Yarden
Elior Peles
Original Assignee
Amgen Inc
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc, Yeda Res & Dev filed Critical Amgen Inc
Publication of NO944112D0 publication Critical patent/NO944112D0/no
Publication of NO944112L publication Critical patent/NO944112L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/4756—Neuregulins, i.e. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO944112A 1992-04-29 1994-10-28 Rekombinat stimuleringsfaktor for neu-reseptoren NO944112L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87743192A 1992-04-29 1992-04-29
PCT/US1993/004128 WO1993022424A1 (en) 1992-04-29 1993-04-28 RECOMBINANT STIMULATING FACTOR OF THE neu RECEPTOR

Publications (2)

Publication Number Publication Date
NO944112D0 true NO944112D0 (no) 1994-10-28
NO944112L NO944112L (no) 1994-12-29

Family

ID=25369947

Family Applications (1)

Application Number Title Priority Date Filing Date
NO944112A NO944112L (no) 1992-04-29 1994-10-28 Rekombinat stimuleringsfaktor for neu-reseptoren

Country Status (11)

Country Link
EP (1) EP0583050A3 (no)
JP (1) JPH07506488A (no)
KR (1) KR950701379A (no)
CN (1) CN1080959A (no)
AU (1) AU4228693A (no)
CA (1) CA2134564A1 (no)
FI (1) FI945085A0 (no)
MX (1) MX9302475A (no)
NO (1) NO944112L (no)
WO (1) WO1993022424A1 (no)
ZA (1) ZA933021B (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530109A (en) * 1991-04-10 1996-06-25 Ludwig Institute For Cancer Research DNA encoding glial mitogenic factors
US7135456B1 (en) 1991-04-10 2006-11-14 Acorda Therapeutics, Inc. Glial mitogenic factors, their preparation and use
US7094749B1 (en) 1991-04-10 2006-08-22 Acorda Therapeutics, Inc. Glial mitogenic factors, their preparation and use
US7285531B1 (en) 1991-04-10 2007-10-23 Acorda Therapeutics, Inc. Method for prophylaxis or treatment of a nervous system, pathophysiological condition involving a glial growth factor sensitive cell by administration of a glial growth factor
US7319019B1 (en) 1991-04-10 2008-01-15 Acorda Therapeutics, Inc. Glial mitogenic factors lacking an N-terminal signal sequence
US5834229A (en) 1991-05-24 1998-11-10 Genentech, Inc. Nucleic acids vectors and host cells encoding and expressing heregulin 2-α
US5367060A (en) * 1991-05-24 1994-11-22 Genentech, Inc. Structure, production and use of heregulin
IL101943A0 (en) * 1991-05-24 1992-12-30 Genentech Inc Structure,production and use of heregulin
WO1994028133A1 (en) * 1993-05-21 1994-12-08 Amgen Inc. Recombinant neu differentiation factors
US6251597B1 (en) 1996-03-29 2001-06-26 Millennium Pharmaceuticals, Inc. Methods for detecting fohy030
US6825320B1 (en) 1995-03-29 2004-11-30 Millenium Pharmaceuticals, Inc. FOHY03 polypeptides
US5633161A (en) 1995-03-29 1997-05-27 Millennium Pharmaceuticals, Inc. Murine gene fomy030 coding for tumor progression inhibitor
US6794185B1 (en) 1995-03-29 2004-09-21 Millennium Pharmaceuticals, Inc. fohy030 nucleic acid molecules
US6312909B1 (en) 1996-03-29 2001-11-06 Millennium Pharmaceuticals, Inc. Compositions and methods for the diagnosis prevention and treatment of tumor progression
AU727606B2 (en) * 1996-07-12 2000-12-14 Genentech Inc. Gamma-heregulin
WO1998035036A1 (en) * 1997-02-10 1998-08-13 Genentech, Inc. Heregulin variants
US6136558A (en) * 1997-02-10 2000-10-24 Genentech, Inc. Heregulin variants
US20010023241A1 (en) 1998-02-04 2001-09-20 Sliwkowski Mark X. Use of heregulin as a growth factor
CA2455830C (en) 2001-07-31 2012-10-09 Wayne State University Hybrid proteins with neuregulin heparin-binding domain for targeting to heparan sulfate proteoglycans
DK2420565T3 (en) 2006-02-23 2017-12-04 Viacyte Inc APPLICABLE COMPOSITIONS AND METHODS FOR CULTIVATING DIFFERENTIBLE CELLS
CA2907326A1 (en) 2008-11-04 2010-05-14 Chad Green Stem cell aggregate suspension compositions and methods for differentiation thereof
AU2013248265B2 (en) 2012-11-08 2018-11-01 Viacyte, Inc. Scalable primate pluripotent stem cell aggregate suspension culture and differentiation thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO921040L (no) * 1991-03-17 1992-09-18 Yeda Res & Dev Stimulerende faktor for neu-reseptoren
IL101943A0 (en) * 1991-05-24 1992-12-30 Genentech Inc Structure,production and use of heregulin

Also Published As

Publication number Publication date
FI945085A (fi) 1994-10-28
CN1080959A (zh) 1994-01-19
CA2134564A1 (en) 1993-11-11
ZA933021B (en) 1993-11-12
NO944112L (no) 1994-12-29
FI945085A0 (fi) 1994-10-28
WO1993022424A1 (en) 1993-11-11
AU4228693A (en) 1993-11-29
EP0583050A3 (en) 1994-10-05
KR950701379A (ko) 1995-03-23
MX9302475A (es) 1994-05-31
EP0583050A2 (en) 1994-02-16
JPH07506488A (ja) 1995-07-20

Similar Documents

Publication Publication Date Title
NO944112L (no) Rekombinat stimuleringsfaktor for neu-reseptoren
FI935175A0 (fi) Tyrosinkinas- HER4-humanreceptor
DK0605442T3 (da) Rekombinante antistoffer til human terapi
DE69329660T2 (de) IMPLANTIERBARE ANSATZSTüCKE
DE69223264D1 (de) Implantierbare leitung
DE69304176T2 (de) Verbinder
DE69320598T2 (de) Verbinder
DE69327720D1 (de) Endothelin rezeptor antagonisten
NO982550D0 (no) 1L-13 reseptor polypeptid
IL97005A0 (en) Recombinant human anti-cd18 antibodies
EP0438312A3 (en) Recombinant human anti-cd18 antibodies
NO921040D0 (no) Stimulerende faktor for neu-reseptoren
DE69315043D1 (de) Verbinder
DE69301589T2 (de) Verbinder
DE69311024D1 (de) Verbinder
DE69219902T2 (de) Gleichstrom-Wechselstrom Versorgung
DE69315304D1 (de) Verbinder
ZA921944B (en) Stimulating factor of the neu receptor
GB9224057D0 (en) Novel protein kinase receptors
NO179996C (no) Brusede preparater inneholdende 5HT1-lignende reseptorantagonister
GB9007065D0 (en) Recombinant protein receptor
IT229184Y1 (it) Snodo per poltrona
ZA925615B (en) Recombinant antibodies for human therapy
DE9206790U1 (de) Vorwärmsystem
FI222U1 (fi) Haollare foer en kos juvrar